Upfront Immunotherapy for Metastatic Kidney Cancer
0 Mga view
• 06/26/23
0
0
I-embed
administrator
Mga subscriber
Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento